1. Product Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Migraine Treatment Devices Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Type
(External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial
Magnetic Stimulator (sTMS), gammaCore Non-Invasive Vagus Nerve Stimulator,
Others)
5.2.2.
By
Site (Handheld, Headband, Others)
5.2.3.
By
Product Type (Prescription and Over The Counter)
5.2.4.
By
Therapy (Acute Therapy and Preventive Therapy)
5.2.5.
By
Distribution Channel (Hospital Based Pharmacies, Retail Pharmacies, Online
Pharmacies)
5.2.6.
By
End User (Hospitals & Clinics, Homecare, Others)
5.2.7.
By
Region
5.2.8.
By
Company (2023)
5.3. Market Map
6.
North
America Migraine Treatment Devices Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By
Type
6.2.2. By Site
6.2.3. By Product Type
6.2.4. By Therapy
6.2.5. By Distribution Channel
6.2.6. By End User
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Migraine Treatment Devices Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Type
6.3.1.2.2.
By
Site
6.3.1.2.3.
By
Product Type
6.3.1.2.4.
By
Therapy
6.3.1.2.5.
By
Distribution Channel
6.3.1.2.6.
By
End User
6.3.2.
Canada
Migraine Treatment Devices Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Type
6.3.2.2.2.
By
Site
6.3.2.2.3.
By
Product Type
6.3.2.2.4.
By
Therapy
6.3.2.2.5.
By
Distribution Channel
6.3.2.2.6.
By
End User
6.3.3.
Mexico
Migraine Treatment Devices Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Type
6.3.3.2.2.
By
Site
6.3.3.2.3.
By
Product Type
6.3.3.2.4.
By
Therapy
6.3.3.2.5.
By
Distribution Channel
6.3.3.2.6.
By
End User
7.
Europe
Migraine Treatment Devices Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Type
7.2.2.
By
Site
7.2.3.
By
Product Type
7.2.4.
By
Therapy
7.2.5.
By
Distribution Channel
7.2.6.
By
End User
7.2.7.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Migraine Treatment Devices Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Type
7.3.1.2.2.
By
Site
7.3.1.2.3.
By
Product Type
7.3.1.2.4.
By
Therapy
7.3.1.2.5.
By
Distribution Channel
7.3.1.2.6.
By
End User
7.3.2.
United
Kingdom Migraine Treatment Devices Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Type
7.3.2.2.2.
By
Site
7.3.2.2.3.
By
Product Type
7.3.2.2.4.
By
Therapy
7.3.2.2.5.
By
Distribution Channel
7.3.2.2.6.
By
End User
7.3.3.
Italy
Migraine Treatment Devices Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By
Type
7.3.3.2.2.
By
Site
7.3.3.2.3.
By
Product Type
7.3.3.2.4.
By
Therapy
7.3.3.2.5.
By
Distribution Channel
7.3.3.2.6.
By
End User
7.3.4.
France
Migraine Treatment Devices Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Type
7.3.4.2.2.
By
Site
7.3.4.2.3.
By
Product Type
7.3.4.2.4.
By
Therapy
7.3.4.2.5.
By
Distribution Channel
7.3.4.2.6.
By
End User
7.3.5.
Spain
Migraine Treatment Devices Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Type
7.3.5.2.2.
By
Site
7.3.5.2.3.
By
Product Type
7.3.5.2.4.
By
Therapy
7.3.5.2.5.
By
Distribution Channel
7.3.5.2.6.
By
End User
8.
Asia-Pacific
Migraine Treatment Devices Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Type
8.2.2.
By
Site
8.2.3.
By
Product Type
8.2.4.
By
Therapy
8.2.5.
By
Distribution Channel
8.2.6.
By
End User
8.2.7.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China
Migraine Treatment Devices Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Type
8.3.1.2.2.
By
Site
8.3.1.2.3.
By
Product Type
8.3.1.2.4.
By
Therapy
8.3.1.2.5.
By
Distribution Channel
8.3.1.2.6.
By
End User
8.3.2.
India
Migraine Treatment Devices Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Type
8.3.2.2.2.
By
Site
8.3.2.2.3.
By
Product Type
8.3.2.2.4.
By
Therapy
8.3.2.2.5.
By
Distribution Channel
8.3.2.2.6.
By
End User
8.3.3.
Japan
Migraine Treatment Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Type
8.3.3.2.2.
By
Site
8.3.3.2.3.
By
Product Type
8.3.3.2.4.
By
Therapy
8.3.3.2.5.
By
Distribution Channel
8.3.3.2.6.
By
End User
8.3.4.
South
Korea Migraine Treatment Devices Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Type
8.3.4.2.2.
By
Site
8.3.4.2.3.
By
Product Type
8.3.4.2.4.
By
Therapy
8.3.4.2.5.
By
Distribution Channel
8.3.4.2.6.
By
End User
8.3.5.
Australia
Migraine Treatment Devices Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Type
8.3.5.2.2.
By
Site
8.3.5.2.3.
By
Product Type
8.3.5.2.4.
By
Therapy
8.3.5.2.5.
By
Distribution Channel
8.3.5.2.6.
By
End User
9.
South
America Migraine Treatment Devices Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Type
9.2.2.
By
Site
9.2.3.
By
Product Type
9.2.4.
By
Therapy
9.2.5.
By
Distribution Channel
9.2.6.
By
End User
9.2.7.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Migraine Treatment Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Type
9.3.1.2.2.
By
Site
9.3.1.2.3.
By
Product Type
9.3.1.2.4.
By
Therapy
9.3.1.2.5.
By
Distribution Channel
9.3.1.2.6.
By
End User
9.3.2.
Argentina
Migraine Treatment Devices Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Type
9.3.2.2.2.
By
Site
9.3.2.2.3.
By
Product Type
9.3.2.2.4.
By
Therapy
9.3.2.2.5.
By
Distribution Channel
9.3.2.2.6.
By
End User
9.3.3.
Colombia
Migraine Treatment Devices Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Type
9.3.3.2.2.
By
Site
9.3.3.2.3.
By
Product Type
9.3.3.2.4.
By
Therapy
9.3.3.2.5.
By
Distribution Channel
9.3.3.2.6.
By
End User
10. Middle East and Africa Migraine
Treatment Devices Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Type
10.2.2. By Site
10.2.3. By Product Type
10.2.4. By Therapy
10.2.5. By Distribution Channel
10.2.6. By End User
10.2.7. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Migraine Treatment Devices
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Type
10.3.1.2.2.
By
Site
10.3.1.2.3.
By
Product Type
10.3.1.2.4.
By
Therapy
10.3.1.2.5.
By
Distribution Channel
10.3.1.2.6.
By
End User
10.3.2. Saudi Arabia Migraine Treatment Devices
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Type
10.3.2.2.2.
By
Site
10.3.2.2.3.
By
Product Type
10.3.2.2.4.
By
Therapy
10.3.2.2.5.
By
Distribution Channel
10.3.2.2.6.
By
End User
10.3.3. UAE Migraine Treatment Devices
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Type
10.3.3.2.2.
By
Site
10.3.3.2.3.
By
Product Type
10.3.3.2.4.
By
Therapy
10.3.3.2.5.
By
Distribution Channel
10.3.3.2.6.
By
End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger
& Acquisition (If Any)
12.2.
Product
Launches (If Any)
12.3.
Recent
Developments
13. Porter’s Five Forces Analysis
13.1.
Competition
in the Industry
13.2.
Potential
of New Entrants
13.3.
Power
of Suppliers
13.4.
Power
of Customers
13.5.
Threat
of Substitute Products
14. Competitive Landscape
14.1.
Theranica Bio-Electronics Ltd.
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
CEFALY Technology SPRL
14.3.
ElectroCore, Inc.
14.4.
eNeura Inc.
14.5.
Neurolief Ltd.
14.6.
Cirrus Healthcare Products LLC
14.7.
Neuros Medical Inc.
14.8.
Salvia BioElectronics B.V.
14.9.
Theranica Bio-Electronics Ltd.
14.10.
Dr Reddy's Laboratories Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer